LIVE
6.7M influencer listings 🏢78.1K sponsor listings 🌍92.4B combined audience reach 📊13 platforms indexed 🗺️130+ countries covered 🏷️10,000+ niches 🦋2.9M Bluesky creators 🎙️1.3M podcast creators 🟣1.1M Twitch creators 📈394.5K Pinterest creators 🥊214.1K Kick creators 𝕏202.7K X creators 🐘201.4K Mastodon creators 115.1K YouTube creators 🎵91.6K TikTok creators ✈️84.9K Telegram creators 🎮11.6K Discord creators 🎬4.6K Rumble creators 📈3.9K Substack creators 🧵2.7K Threads creators 6.7M influencer listings 🏢78.1K sponsor listings 🌍92.4B combined audience reach 📊13 platforms indexed 🗺️130+ countries covered 🏷️10,000+ niches 🦋2.9M Bluesky creators 🎙️1.3M podcast creators 🟣1.1M Twitch creators 📈394.5K Pinterest creators 🥊214.1K Kick creators 𝕏202.7K X creators 🐘201.4K Mastodon creators 115.1K YouTube creators 🎵91.6K TikTok creators ✈️84.9K Telegram creators 🎮11.6K Discord creators 🎬4.6K Rumble creators 📈3.9K Substack creators 🧵2.7K Threads creators
BCRF
🤝

Make a deal with BCRF

🔒 Paid proposals held safely in escrow — released only when the work's approved.

Every booking is a normal escrow-protected deal.

Followers
2K
Total likes
33.6K
Videos
311
Following
202
🎁 Free analysisfor BCRF

Known for

The FDA has approved Enhertu for certain people with HER2-positive early-stage breast cancer—until now, this powerful drug was used in those with metastatic disease. EnhertuⓇ is unique because it is an antibody-drug conjugate (ADC)—the antibody helps deliver the treatment directly to HER2-expressing cancer cells, allowing it to work in a more targeted manner so that it’s effective at killing the tumors and sparing neighboring cells. This approval is based on the DESTINY-Breast11 and DESTINY-Brea3.8K views The FDA has approved Enhertu for certain people with HER2-positive early-stage breast cancer—until now, this powerful drug was used in those with metastatic disease. EnhertuⓇ is unique because it is an antibody-drug conjugate (ADC)—the antibody helps deliver the treatment directly to HER2-expressing cancer cells, allowing it to work in a more targeted manner so that it’s effective at killing the tumors and sparing neighboring cells. This approval is based on the DESTINY-Breast11 and DESTINY-Brea Nearly one year after her breast cancer diagnosis, @Katie Thurston reflects on thrivership, community, and the importance of funding research. At this year's Hot Pink Party (just two weeks after having a double mastectomy), Katie shared why supporting metastatic breast cancer research is so important to her—and how organizations like BCRF help bring hope to patients and families facing this disease. #bcrf #breastcancer #metastaticbreastcancer #katiethurston3.3K views Nearly one year after her breast cancer diagnosis, @Katie Thurston reflects on thrivership, community, and the importance of funding research. At this year's Hot Pink Party (just two weeks after having a double mastectomy), Katie shared why supporting metastatic breast cancer research is so important to her—and how organizations like BCRF help bring hope to patients and families facing this disease. #bcrf #breastcancer #metastaticbreastcancer #katiethurston Ever have a burning question that you wish you could ask a breast surgeon or oncologist? Join us for a live discussion on Friday, May 14th at 1pm ET exploring some of the biggest myths, facts, and questions in breast cancer today. Hear from BCRF researchers Veronica Jones, MD and Evanthia Roussos Torres, MD, PhD, moderated by Sadia Haque Zapp, as they break down what you really need to know about topics like AI-guided screening, hormone therapy and menopause, DCIS, GLP-1s, and more. Sign up for 1.3K views Ever have a burning question that you wish you could ask a breast surgeon or oncologist? Join us for a live discussion on Friday, May 14th at 1pm ET exploring some of the biggest myths, facts, and questions in breast cancer today. Hear from BCRF researchers Veronica Jones, MD and Evanthia Roussos Torres, MD, PhD, moderated by Sadia Haque Zapp, as they break down what you really need to know about topics like AI-guided screening, hormone therapy and menopause, DCIS, GLP-1s, and more. Sign up for Today is #MetastaticBreastCancerAwarenessDay. We explain what this term means and how BCRF is advancing MBC research as the largest private funder in the world. BCRF is committed to helping people with MBC now and moving research forward so that one day no one has stage 4. Learn more about MBC at the link in bio. https://bit.ly/3S5A3xf #ResearchIsTheReason #BreastCancerAwarenessMonth #breastcancer #breastcancerawareness #breastcancerresearch #breastcancerresearchfoundation #bcrf #metastaticcance1K views Today is #MetastaticBreastCancerAwarenessDay. We explain what this term means and how BCRF is advancing MBC research as the largest private funder in the world. BCRF is committed to helping people with MBC now and moving research forward so that one day no one has stage 4. Learn more about MBC at the link in bio. https://bit.ly/3S5A3xf #ResearchIsTheReason #BreastCancerAwarenessMonth #breastcancer #breastcancerawareness #breastcancerresearch #breastcancerresearchfoundation #bcrf #metastaticcance

📊 Engagement & reach

Engagement rate · Average
5.38%
Likes + comments ÷ followers. On TikTok this is the real currency — a highly-engaged mid-size creator often out-performs a bigger, passive one.
Avg likes / video
108
Typical likes on a recent post — the clearest proof of how hard the audience reacts.
Avg views / video
1.2K
Measured across recent posts — the real reach a sponsored video earns.
Posting cadence
0.07 / week
A more selective poster — each video gets room to breathe.
Follower / following
9.9×
Follows just 202 back — a lopsided ratio typical of a real creator with a genuine audience, not a follow-for-follow account.

🏷️ Niche & audience

Content niche
Others
The lane this creator is known for — match it to your product for the most native-feeling collab.

📹 Recent videos

Latest posts straight from BCRF's TikTok.

@bcrfcure

💡 Facts

👁️Averages 1.2K views per stream.
📤Posts about 0.1× per week.
💬5.38% engagement rate.

👥 Audience demographics

Estimated

Modeled from this creator's niche, platform & region — a niche benchmark, not this creator's real audience data.

Gender split
Male 49% Female 51%
Age · peak 18-24
13-1720%
18-2442%
25-3421%
35-4412%
45+5%
Top geographies
  • United States34%
  • India11%
  • United Kingdom8%
  • Brazil6%
  • Indonesia5%
Likely interests
EntertainmentLifestyleTrending

🕵️ Fake follower check

Estimated
46/100
Fair Credibility score
72%
Mixed Real audience
Medium Fake-follower risk
High Data confidence
  • Est. 72% real, active audience · Medium fake-follower risk.
  • Engagement (~0.6× of followers engage each post) is around typical for TikTok.
  • 5.38% engagement — below the ~15% typical for this size.

Heuristic estimate from engagement, follower ratios, account age & growth — a screening signal, not a guarantee.

💚 Brand affinity

Estimated

Brands BCRF's audience is most likely to respond to — from detected sponsorships in this niche.

Repeat Sociabuzz Wise Donatty Instalasi Teknologi Informasi - Sardjito

About

BCRF is the largest private funder of breast cancer research in the world.

📸 Gallery

Recent content

Could what’s happening in your gut affect your risk for breast cancer? We asked BCRF researcher Dr. Laura Esserman about the connection between the gut microbiome and breast cancer. Plus, she shares how much fiber you should eat in a day for optimal health. #breastcancer #bcrf #diet #fiber
123 views · 16 days ago
When Arjun Bhayani’s grandmother was diagnosed with triple-negative metastatic breast cancer, he wanted to do more than feel helpless, he wanted to help fuel progress. After learning about BCRF and the critical role research plays in advancing better treatments and outcomes, Arjun turned his passion for music into action. In 2025, he organized his first fundraising concert to support breast cancer research, bringing together his community through an evening of music, connection, and hope. Inspi
119 views · 1 month ago
Research is changing what's possible for patients with postpartum breast cancer. BCRF investigator Dr. Virginia Borges and her team have helped uncover why postpartum breast cancers can behave more aggressively—and are working toward a novel treatment that could change outcomes for patients. Every discovery brings us one step closer to more effective, personalized treatments. #breastcancer #postpartumbreastcancer #bcrf #research
1K views · 2 months ago
Elizabeth Hurley has been a passionate advocate for breast cancer research, serving as the Global Ambassador for Esteé Lauder's Breast Cancer Campaign over the last 3 decades. In conversation with BCRF, she reflects on what inspired her to join the movement—and why she’s remained committed ever since. #bcrf #breastcancer #elizabethhurley
958 views · 2 months ago
Why do some breast cancer patients experience chemotherapy-related nerve damage more often than others? A study led by BCRF investigator Dr. Sonya Reid is helping answer that question by focusing on Black breast cancer patients and uncovering factors that may contribute to higher rates of chemotherapy-related neuropathy. Representation in research matters: When communities are included, we get the insights needed to improve care for everyone.
309 views · 3 months ago
Nearly one year after her breast cancer diagnosis, @Katie Thurston reflects on thrivership, community, and the importance of funding research. At this year's Hot Pink Party (just two weeks after having a double mastectomy), Katie shared why supporting metastatic breast cancer research is so important to her—and how organizations like BCRF help bring hope to patients and families facing this disease. #bcrf #breastcancer #metastaticbreastcancer #katiethurston
3.3K views · 3 months ago
Research made it possible for Samantha’s breast cancer to be detected at the earliest possible stage—and continues to advance understanding of genetic risk and early detection. After her diagnosis, Samantha joined The Pink Agenda, a partner of BCRF, to support the science driving these breakthroughs. Research is changing what’s possible—earlier detection, improved understanding of risk, and more informed care. Join us in advancing lifesaving research by giving today at BCRF.org/donate. #bcrf #br
528 views · 3 months ago
Because of her awareness of family history, risk-informed screening, and early surveillance, Samatha was able to detect her breast cancer at the earliest stage—DCIS (stage 0). Today, she serves as Vice President of The Pink Agenda and a proud supporter of BCRF. Her story shows how research-driven screening and early detection can change outcomes. BCRF funds the science that helps identify risk earlier and improve care for all. #bcrf #breastcancer #dcis #ductalcarcinomainsitu
959 views · 3 months ago
The FDA has approved Enhertu for certain people with HER2-positive early-stage breast cancer—until now, this powerful drug was used in those with metastatic disease. EnhertuⓇ is unique because it is an antibody-drug conjugate (ADC)—the antibody helps deliver the treatment directly to HER2-expressing cancer cells, allowing it to work in a more targeted manner so that it’s effective at killing the tumors and sparing neighboring cells. This approval is based on the DESTINY-Breast11 and DESTINY-Brea
3.8K views · 3 months ago
Ever have a burning question that you wish you could ask a breast surgeon or oncologist? Join us for a live discussion on Friday, May 14th at 1pm ET exploring some of the biggest myths, facts, and questions in breast cancer today. Hear from BCRF researchers Veronica Jones, MD and Evanthia Roussos Torres, MD, PhD, moderated by Sadia Haque Zapp, as they break down what you really need to know about topics like AI-guided screening, hormone therapy and menopause, DCIS, GLP-1s, and more. Sign up for
1.3K views · 4 months ago
We're thrilled to announce our $70.3 million commitment to breast cancer research for 2024-25! Our grants support more than 260 scientists at leading academic and medical institutions across 15 countries. BCRF is once again the largest private funder of breast cancer research—and metastatic breast cancer research—in the world. This year, metastatic breast cancer research comprises nearly half of our portfolio, funding 86 projects. We're doubling down on our commitments to achieving equitable pro
868 views · 1 year ago
Today is #MetastaticBreastCancerAwarenessDay. We explain what this term means and how BCRF is advancing MBC research as the largest private funder in the world. BCRF is committed to helping people with MBC now and moving research forward so that one day no one has stage 4. Learn more about MBC at the link in bio. https://bit.ly/3S5A3xf #ResearchIsTheReason #BreastCancerAwarenessMonth #breastcancer #breastcancerawareness #breastcancerresearch #breastcancerresearchfoundation #bcrf #metastaticcance
1K views · 2 years ago

⚐ Report an incorrect claim

Frequently asked questions

How much does BCRF charge for a sponsorship?
BCRF hasn't published fixed prices yet. Send a proposal through SocialDB and agree terms directly — your payment is held in escrow until the work is approved.
How do I contact BCRF for a brand deal or collaboration?
Send a paid deal or collab request right here on SocialDB — we notify BCRF, and once they accept, your payment is held safely in escrow and released when the work is approved. You don't need to track down an email.
How many followers does BCRF have?
BCRF has 2,008 followers on TikTok.

✉ Message BCRF

Reaching out to influencers is a Pro feature. Upgrade to message any influencer directly — perfect for brands and agencies booking sponsorships.

See Pro $9.95/mo →

Already Pro? Log in.

🎤 Event / appearance with BCRF

Booking an event / appearance is a Pro feature. Upgrade to book BCRF for an in-person or virtual appearance — payment held safely in escrow until the event is done.

See Pro $9.95/mo →

Already Pro? Log in.

✉️ Contact